FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Persimmon lower forward order book, reflecting challenging trading conditions

Persimmon Plc (LON:PSN), has provided an update on trading for the period from 1 January 2023 to 31 March 2023, ahead of its Annual General Meeting which is being held..

GSK achieves excellent performance across Vaccines, Specialty and General Medicine

GSK plc (LON:GSK) has announced its 1st quarter results. Q1 2023 performance highlights: · Sales performance reflected lower COVID-19 solutions sales versus Q1 2022. Excluding COVID-19 solutions, sales grew +10%..

CRH expect first-half sales, EBITDA and margin to be ahead of prior year period

CRH plc (LON:CRH) has announced its trading update for April 2023. Key Highlights ·    Positive start to the year; Q1 sales and EBITDA ahead ·    Integrated solutions strategy continuing to..

Bunzl delivers resilient growth, with Q1 group revenue up 8.4%

Bunzl plc (LON:BNZL), the specialist international distribution and services Group, has announced its trading statement for the period since 31 December 2022. Bunzl’s diversified business model has delivered resilient growth,..

Whitbread reports significant profit uplift to above pre-pandemic levels

Whitbread plc (LON:WTB) has announced its preliminary results. Throughout this release all percentage growth comparisons are made comparing the current year (FY23) performance for the 52 weeks to 2 March..

Anglo American Q1 production increased by 9%

Anglo American plc (LON:AAL) has announced its production report for the first quarter ended 31 March 2023. Duncan Wanblad, Chief Executive of Anglo American, said: “Our production in the first..

GSK receives EMA validation for Jemperli plus chemotherapy

GSK plc (LON/NYSE: GSK) has announced that the European Medicines Agency (EMA) validated the Company’s Type II Variation for a potential new indication for Jemperli (dostarlimab) in combination with chemotherapy..

Glencore Q1 production broadly in line with expectations

Glencore plc (LON:GLEN) has announced its first quarter production report 2023. Glencore Chief Executive Officer, Gary Nagle: “First quarter production was broadly in line with our expectations, accounting for portfolio..

Antofagasta Q1 production and cost performance in line with guidance

Antofagasta plc (LON:ANTO) has announced its Q1 2023 production report. HIGHLIGHTS PRODUCTION ·    Copper production in Q1 2023 at 145,900 tonnes was in line with guidance, 5.1% higher than in the..

Smurfit Kappa to release 2023 Q1 trading update on 28 April 2023

Smurfit Kappa Group plc (LON:SKG), one of the world’s largest integrated manufacturers of paper-based packaging products, with operations in Europe and the Americas, has announced it will release a 2023..

Convatec acquires anti-infective nitric oxide technology platform

Convatec Group Plc [LON:CTEC] has announced it has acquired the anti-infective nitric oxide technology platform of 30 Technology Limited which includes new product assets and research and development. In addition..

Antofagasta appoints Heather Lawrence as an Independent Non-Executive Director

Antofagasta plc (LON:ANTO) has announced that the Board of the Company has appointed Heather Lawrence as an Independent Non-Executive Director and member of the Company’s Audit and Risk Committee with..

Anglo American welcome decision from Committee of Ministers in support of LBIP

Anglo American plc (LON:AAL) has welcomed the decision in Chile by the Committee of Ministers to approve the environmental permit application for the Los Bronces Integrated Project (LBIP), setting up..

GSK to acquire late-stage biopharmaceutical company, BELLUS Health

GSK plc (LON/NYSE: GSK) and BELLUS Health Inc. (TSX/NASDAQ: BLU) has announced that they have entered into an agreement under which GSK will acquire BELLUS, a Canada-based, late-stage biopharmaceutical company..

GSK positive results from the pivotal phase III trials for gepotidacin

GSK plc (LON/NYSE: GSK) presented positive results from the pivotal EAGLE-2 and EAGLE-3 phase III trials for gepotidacin, an investigational, first-in-class oral antibiotic with a novel mechanism of action for..

National Grid performance in line with expectations

National Grid plc (LON:NG) has issued a pre-close update ahead of announcing results for the year ending 31 March 2023 on 18 May 2023. Overall, the Group’s performance is in..

Imperial Brands on track to meet full-year guidance

Imperial Brands plc (LON:IMB) has announced its pre-close trading statement. ·      Robust tobacco pricing and stable aggregate market share across top-five combustible markets – against a strong comparator ·      Product launches across..

Tesco deliver strong performance with group sales up 5.3%

Tesco plc (LON:TSCO) has announced its preliminary results for 2022/2023. Performance highlights1,2: FY 22/23 FY 21/22 Change at actual rates Change at constant rates Group sales (exc. VAT, exc. fuel)3..

Anglo American De Beers sees good demand for rough diamonds in cycle 3

Anglo American plc (LON:AAL) has announced the value of rough diamond sales (Global Sightholder Sales and Auctions) for De Beers’ third sales cycle of 2023, amounting to $540 million. Cycle..

Unite Students making strong progress with 90% of rooms already sold

Unite Group plc (LON:UTG) Unite Students, the UK’s leading owner, manager and developer of student accommodation, today announces an update on current trading and quarterly property valuations for the Unite..

Search

Funds

FTSE 100

Search

Funds

FTSE 100

FTSE 100

Funds